Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about BPMC

Recent news which mentions BPMC

< Previous 1 2 3 4 5 Next >

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022

March 01, 2022

Blueprint Medicines, Proteovant Collaboration For Protein Degrader Therapies

February 28, 2022

Stocks That Hit 52-Week Lows On Monday

February 28, 2022

Stocks That Hit 52-Week Lows On Friday

February 25, 2022

Where Blueprint Medicines Stands With Analysts

February 17, 2022

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa

February 16, 2022

Earnings Scheduled For February 16, 2022

February 16, 2022

Earnings Preview: Blueprint Medicines

February 15, 2022

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More

February 13, 2022

EMA's Advisory Committee Recommends Approval Of Blueprint Medicines' Avapritinib In Blood Disorder

January 28, 2022

Analyst Ratings For Blueprint Medicines

January 25, 2022

10 Biggest Price Target Changes For Tuesday

January 25, 2022

50 Biggest Movers From Yesterday

January 06, 2022

34 Stocks Moving In Wednesday's Mid-Day Session

January 05, 2022

Blueprint Medicines Expands Precision Therapy With Lengo Therapeutics Acquisition

November 29, 2021

Zai Lab Inks Back To Back Licensing Agreements For Cancer And Psychiatric Candidates

November 09, 2021

Blueprint Medicines Corp (BPMC) Q3 2021 Earnings Call Transcript

October 28, 2021

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug

October 28, 2021

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More

October 24, 2021

My 2019 Report Card: Up 319%

August 15, 2021

Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar

August 05, 2021

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs

July 29, 2021

Blueprint Medicines: Q2 Earnings Insights

July 29, 2021

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More

July 25, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.